IP Library › Granted Patent US 8,168,616
Granted Patent B1
US 8,168,616 · App. 10/416,039 · Granted May 1, 2012

Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,168,616
App. No.
10/416,039
Granted
May 1, 2012
Kind
B1
Abstract

The invention relates to a combination comprising the renin inhibitor of formula (I) or a pharmaceutically acceptable salt thereof.

Claims (4)

1. A pharmaceutical composition comprising the renin inhibitor of formula (I)

as a hemi-fumarate, valsartan or a pharmaceutically acceptable sale thereof, and a carrier.

2. The composition according to claim 1 for the treatment of hypertension.

3. The composition according to claim 1 for simultaneous separate or sequential use.

Assignments (4)
CHANGE OF ADDRESS Recorded Mar 21, 2017
From: NODEN PHARMA DAC
To: NODEN PHARMA DAC
Reel/Frame 042084/0980 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE'S ADDRESS PREVIOUSLY RECORDED ON REEL 039481 FRAME 0233. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 29, 2016
From: NOVARTIS AG; NOVARTIS PHARMA AG; SPEEDEL HOLDING AG
To: NODEN PHARMA DAC
Reel/Frame 040003/0579 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2016
From: NOVARTIS AG; NOVARTIS PHARMA AG; SPEEDEL HOLDING AG
To: NODEN PHARMA DAC
Reel/Frame 039481/0233 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2012
From: HEWITT, WILLIAM; VASELLA, DANIEL LUCIUS; WEBB, RANDY LEE
To: NOVARTIS AG
Reel/Frame 027916/0852 →